aod9604 igf-1 levels study Mechanisms of Disease: metabolic effects of growth hormone and insulin-like growth factor 1 AOD 9604: Peptide Claims vs
Description
Oral Protocols: Daily oral doses of 1, 5, 10, 20, and 30 mg were evaluated over 12 weeks
nothing crazy but steady
Once the peptides are reconstituted (mixed with bacteriostatic water), they must be stored in the fridge to maintain stability
[3] One study focused on the potential role of the tripeptide concerning dermal papilla cells (DPCs)
AOD-9604 targets fat tissue directly without systemic hormonal disruption
Histological and biochemical analyses in animal models show reduced markers of cartilage degradation in systems exposed to the peptide compared to controls
